Sign up to save your podcasts
Or
Share The Era of Geographic Atrophy Treatment Begins
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
The Era of Geographic Atrophy Treatment Begins
The FDA approval of pegcetacoplan (Syfovre, Apellis Pharmaceuticals) is a historic moment for the field of retina, finally providing a treatment option for patients with geographic atrophy. Allen C. Ho, MD, and Robert L. Avery, MD, share their initial reactions to the approval and discuss the potential effect on patient care and clinical practice.
View all episodes
By Retina Today
4.4
1717 ratings
The FDA approval of pegcetacoplan (Syfovre, Apellis Pharmaceuticals) is a historic moment for the field of retina, finally providing a treatment option for patients with geographic atrophy. Allen C. Ho, MD, and Robert L. Avery, MD, share their initial reactions to the approval and discuss the potential effect on patient care and clinical practice.
More shows like New Retina Radio by Eyetube
View all
Ophthalmology off the Grid by Eyetube
43 Listeners
White Coat Investor Podcast
2,431 Listeners
JAMA Ophthalmology Author Interviews
5 Listeners
Interesting Times with Ross Douthat
6,897 Listeners
American Journal of Ophthalmology Podcasts Collection
11 Listeners
Headlight in the fog: The Uveitis Podcast
21 Listeners
Experts InSight
50 Listeners
RETINA Journal Podcasts
10 Listeners
Talking Euretina
1 Listeners
Ophthalmology Journal
18 Listeners
Mayo Clinic Ophthalmology Podcast
16 Listeners
ASRS's History of Retina
0 Listeners
ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum
0 Listeners
Your Money Guide on the Side
803 Listeners
RetinaRounds™
0 Listeners